132 related articles for article (PubMed ID: 22489752)
1. Vaginal fetal fibronectin as a predictor of spontaneous preterm delivery in triplet gestations.
Roman AS; Pessel C; Fox N; Klauser CK; Saltzman D; Rebarber A
J Matern Fetal Neonatal Med; 2012 Oct; 25(10):1921-3. PubMed ID: 22489752
[TBL] [Abstract][Full Text] [Related]
2. Combined fetal fibronectin and cervical length and spontaneous preterm birth in asymptomatic triplet pregnancies.
Fox NS; Rebarber A; Roman AS; Klauser CK; Peress D; Saltzman DH
J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2308-11. PubMed ID: 22563765
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of fetal fibronectin to predict preterm birth in twin gestations with symptoms of labor.
Singer E; Pilpel S; Bsat F; Plevyak M; Healy A; Markenson G
Obstet Gynecol; 2007 May; 109(5):1083-7. PubMed ID: 17470586
[TBL] [Abstract][Full Text] [Related]
4. "Blind" vaginal fetal fibronectin as a predictor of spontaneous preterm delivery.
Roman AS; Koklanaris N; Paidas MJ; Mulholland J; Levitz M; Rebarber A
Obstet Gynecol; 2005 Feb; 105(2):285-9. PubMed ID: 15684153
[TBL] [Abstract][Full Text] [Related]
5. Fetal fibronectin test predicts delivery before 30 weeks of gestation in high risk women, but increases anxiety.
Shennan A; Jones G; Hawken J; Crawshaw S; Judah J; Senior V; Marteau T; Chinn S; Poston L
BJOG; 2005 Mar; 112(3):293-8. PubMed ID: 15713142
[TBL] [Abstract][Full Text] [Related]
6. The prediction of recurrent preterm birth in patients on 17-alpha-hydroxyprogesterone caproate using serial fetal fibronectin and cervical length.
Romero J; Rebarber A; Saltzman DH; Schwartz R; Peress D; Fox NS
Am J Obstet Gynecol; 2012 Jul; 207(1):51.e1-5. PubMed ID: 22595378
[TBL] [Abstract][Full Text] [Related]
7. Quantitative fetal fibronectin screening in asymptomatic high-risk patients and the spectrum of risk for recurrent preterm delivery.
Kurtzman J; Chandiramani M; Briley A; Poston L; Das A; Shennan A
Am J Obstet Gynecol; 2009 Mar; 200(3):263.e1-6. PubMed ID: 19254585
[TBL] [Abstract][Full Text] [Related]
8. The use of fetal fibronectin testing and cervical length measurement in the prediction of delivery of triplet pregnancies.
Bolt LA; Morrison K; Shennan AH
Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):236-7. PubMed ID: 22770626
[No Abstract] [Full Text] [Related]
9. Vaginal fetal fibronectin as a predictor of spontaneous preterm delivery after multifetal pregnancy reduction.
Roman AS; Rebarber A; Lipkind H; Mulholland J; Minior V; Roshan D
Am J Obstet Gynecol; 2004 Jan; 190(1):142-6. PubMed ID: 14749650
[TBL] [Abstract][Full Text] [Related]
10. Fetal fibronectin as a predictor of spontaneous preterm labour in asymptomatic women with a cervical cerclage.
Duhig KE; Chandiramani M; Seed PT; Briley AL; Kenyon AP; Shennan AH
BJOG; 2009 May; 116(6):799-803. PubMed ID: 19432568
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of additive effect of quantitative fetal fibronectin to cervical length for prediction of spontaneous preterm birth among asymptomatic low-risk women.
Jwala S; Tran TL; Terenna C; McGregor A; Andrel J; Leiby BE; Baxter JK; Berghella V
Acta Obstet Gynecol Scand; 2016 Aug; 95(8):948-55. PubMed ID: 27100022
[TBL] [Abstract][Full Text] [Related]
12. The significance of a positive fetal fibronectin in the setting of a normal cervical length in twin pregnancies.
Fox NS; Rebarber A; Roman AS; Klauser CK; Saltzman DH
Am J Perinatol; 2012 Apr; 29(4):267-72. PubMed ID: 21818730
[TBL] [Abstract][Full Text] [Related]
13. The clinical utility of fetal fibronectin in the prediction of pre-term birth in a low socio-economic setting hospital in Ecuador.
Díaz J; Chedraui P; Hidalgo L; Medina M
J Matern Fetal Neonatal Med; 2009 Feb; 22(2):89-93. PubMed ID: 19085632
[TBL] [Abstract][Full Text] [Related]
14. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
[TBL] [Abstract][Full Text] [Related]
15. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
Shennan A; Crawshaw S; Briley A; Hawken J; Seed P; Jones G; Poston L
BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
[TBL] [Abstract][Full Text] [Related]
16. Fetal fibronectin as a predictor of preterm birth: an overview.
Revah A; Hannah ME; Sue-A-Quan AK
Am J Perinatol; 1998; 15(11):613-21. PubMed ID: 10064202
[TBL] [Abstract][Full Text] [Related]
17. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
Incerti M; Ghidini A; Korker V; Pezzullo JC
Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
[TBL] [Abstract][Full Text] [Related]
18. Biochemical markers predicting pre-term delivery in symptomatic patients: phosphorylated insulin-like growth factor binding protein-1 and fetal fibronectin.
Riboni F; Vitulo A; Dell'avanzo M; Plebani M; Battagliarin G; Paternoster D
Arch Gynecol Obstet; 2011 Dec; 284(6):1325-9. PubMed ID: 21274721
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of fetal fibronectin for predicting preterm birth.
Swamy GK; Simhan HN; Gammill HS; Heine RP
J Reprod Med; 2005 Nov; 50(11):851-6. PubMed ID: 16419634
[TBL] [Abstract][Full Text] [Related]
20. Fetal fibronectin for evaluation of preterm labor in the setting of cervical cerclage.
Benson JE; Landy HJ; Ghidini A; Drassinower D; Poggi SH
J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2330-2. PubMed ID: 22694302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
